330 related articles for article (PubMed ID: 12497547)
21. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
Anaissie EJ
Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
[TBL] [Abstract][Full Text] [Related]
22. Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.
Schieffelin JS; Garcia-Diaz JB; Loss GE; Beckman EN; Keller RA; Staffeld-Coit C; Garces JC; Pankey GA
Transpl Infect Dis; 2014 Apr; 16(2):270-8. PubMed ID: 24628809
[TBL] [Abstract][Full Text] [Related]
23. Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent.
Lodato F; Tamé MR; Montagnani M; Sambri V; Liguori G; Azzaroli F; Costigliola P; Grazi G; Roda E; Mazzella G
Liver Transpl; 2006 Nov; 12(11):1711-4. PubMed ID: 17058254
[TBL] [Abstract][Full Text] [Related]
24. Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.
Grossi PA; Gasperina DD; Barchiesi F; Biancofiore G; Carafiello G; De Gasperi A; Sganga G; Menichetti F; Montagna MT; Pea F; Venditti M; Viale P; Viscoli C; Nanni Costa A
Transplant Proc; 2011; 43(6):2463-71. PubMed ID: 21839295
[TBL] [Abstract][Full Text] [Related]
25. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
26. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
27. A case of subcutaneous Mycoleptodiscus indicus infection in a liver transplant recipient successfully treated with antifungal therapy.
Garrison AP; Procop GW; Vincek V; Moon J; Morris MI; Doblecki-Lewis S; Cleary TJ; Brust D; Rosa-Cunha I
Transpl Infect Dis; 2008 Jun; 10(3):218-20. PubMed ID: 17944811
[TBL] [Abstract][Full Text] [Related]
28. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
Shao PL; Huang LM; Hsueh PR
J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
[TBL] [Abstract][Full Text] [Related]
29. A new era of antifungal therapy.
Wingard JR; Leather H
Biol Blood Marrow Transplant; 2004 Feb; 10(2):73-90. PubMed ID: 14750074
[TBL] [Abstract][Full Text] [Related]
30. Dematiaceous fungi.
Revankar SG
Mycoses; 2007 Mar; 50(2):91-101. PubMed ID: 17305771
[TBL] [Abstract][Full Text] [Related]
31. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
32. Invasive fungal infections and antifungal therapies in solid organ transplant recipients.
Gabardi S; Kubiak DW; Chandraker AK; Tullius SG
Transpl Int; 2007 Dec; 20(12):993-1015. PubMed ID: 17617181
[TBL] [Abstract][Full Text] [Related]
33. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
Pagano L; Akova M; Dimopoulos G; Herbrecht R; Drgona L; Blijlevens N
J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i5-14. PubMed ID: 21177404
[TBL] [Abstract][Full Text] [Related]
35. Phaeohyphomycosis due to Alternaria species in transplant recipients.
Boyce RD; Deziel PJ; Otley CC; Wilhelm MP; Eid AJ; Wengenack NL; Razonable RR
Transpl Infect Dis; 2010 Jun; 12(3):242-50. PubMed ID: 20002611
[TBL] [Abstract][Full Text] [Related]
36. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.
Pastor FJ; Guarro J
Clin Microbiol Infect; 2006 Oct; 12(10):948-60. PubMed ID: 16961630
[TBL] [Abstract][Full Text] [Related]
37. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients.
Netsvyetayeva I; Swoboda-Kopeć E; Paczek L; Fiedor P; Sikora M; Jaworska-Zaremba M; Blachnio S; Luczak M
Mycoses; 2009 May; 52(3):263-5. PubMed ID: 18705664
[TBL] [Abstract][Full Text] [Related]
38. Opportunistic deep cutaneous mycoses in solid organ transplant recipients.
Tessari G; Cagalli A; Girolomoni G
G Ital Dermatol Venereol; 2014 Aug; 149(4):417-22. PubMed ID: 25068229
[TBL] [Abstract][Full Text] [Related]
39. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis.
Nucci M; Anaissie E
Clin Chest Med; 2009 Jun; 30(2):295-306, vii. PubMed ID: 19375636
[TBL] [Abstract][Full Text] [Related]
40. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
Solé A
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
